Gardiner, Sharon J <br/><br/>
Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Jan 2011 
 - 49-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2010.06489.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Allopurinol--adverse effects<br/>Anti-Inflammatory Agents--adverse effects<br/>Azathioprine--adverse effects<br/>Biotransformation<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--adverse effects<br/>Erythrocyte Count<br/>Female<br/>Gastrointestinal Agents--adverse effects<br/>Guanine Nucleotides--blood<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Male<br/>Mercaptopurine--adverse effects<br/>Middle Aged<br/>New Zealand<br/>Red-Cell Aplasia, Pure--blood<br/>Retrospective Studies<br/>Steroids--therapeutic use<br/>Thionucleotides--blood<br/>Time Factors<br/>Treatment Outcome<br/>Xanthine Oxidase--antagonists & inhibitors